3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase NA
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
13
Head and Neck Neoplasms
8
Breast Neoplasms
8
Nasopharyngeal Carcinoma
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Glioma
3
Carcinoma, Squamous Cell
3
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma, Malignant
2
Meningeal Carcinomatosis
2
Glioblastoma
2
Wilms Tumor
1
Virus Diseases
1
Tumor Virus Infections
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Stage IA Uterine Sarcoma
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Interventions
Radiosurgery
24
lenvatinib
19
Radiofrequency Ablation
16
Hepatectomy
13
Sorafenib
12
Surgical Procedures, Operative
9
Radiotherapy
9
camrelizumab
7
Magnetic Resonance Spectroscopy
7
Blood Specimen Collection
7
Bevacizumab
7
sintilimab
6
apatinib
6
Immune Checkpoint Inhibitors
6
Electroporation
6
atezolizumab
5
tislelizumab
4
Yttrium-90
4
Proton Therapy
4
Oxaliplatin
4
Liver Transplantation
4
Doxorubicin
4
Control Groups
4
Cisplatin
4
Chemoembolization, Therapeutic
4
Catheter Ablation
4
spartalizumab
3
entecavir
3
X-Rays
3
Standard of Care
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Hepatocellular
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05339581
2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA
Unknown
78 enrolled